{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:22:33Z","timestamp":1792783353795,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the National Natural Science Foundation of China","award":["82200553"],"award-info":[{"award-number":["82200553"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","award":["2024YFFK0286"],"award-info":[{"award-number":["2024YFFK0286"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiol med"],"DOI":"10.1007\/s11547-026-02237-6","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T05:19:52Z","timestamp":1784870392000},"page":"1523-1534","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of non-insulin glucose-lowering therapies on coronary atherosclerotic plaque progression in diabetes"],"prefix":"10.1007","volume":"131","author":[{"given":"Ran","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongxiu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanjiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujia","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minggang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiyue","family":"Diao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6479-3636","authenticated-orcid":false,"given":"Yong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"key":"2237_CR1","doi-asserted-by":"publisher","first-page":"169","DOI":"10.2991\/jegh.k.201217.001","volume":"11","author":"U Ralapanawa","year":"2021","unstructured":"Ralapanawa U, Sivakanesan R (2021) Epidemiology and the magnitude of coronary artery disease and acute coronary syndrome: a narrative review. J Epidemiol Glob Health 11:169\u2013177. https:\/\/doi.org\/10.2991\/jegh.k.201217.001","journal-title":"J Epidemiol Glob Health"},{"issue":"1","key":"2237_CR2","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12933-018-0763-3","volume":"17","author":"R Kaur","year":"2018","unstructured":"Kaur R, Kaur M, Singh J (2018) Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies. Cardiovasc diabetol 17(1):121","journal-title":"Cardiovasc diabetol"},{"key":"2237_CR3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1177\/2047487319878371","volume":"26","author":"E Dal Canto","year":"2019","unstructured":"Dal Canto E, Ceriello A, Ryd\u00e9n L, Ferrini M, Hansen TB, Schnell O et al (2019) Diabetes as a cardiovascular risk factor: an overview of global trends of macro and micro vascular complications. Eur J Prev Cardiol 26:25\u201332. https:\/\/doi.org\/10.1177\/2047487319878371","journal-title":"Eur J Prev Cardiol"},{"key":"2237_CR4","doi-asserted-by":"publisher","first-page":"487","DOI":"10.2337\/dci19-0066","volume":"43","author":"JB Buse","year":"2019","unstructured":"Buse JB, Wexler DJ, Tsapas A, Rossing P, Mingrone G, Mathieu C et al (2019) 2019 update to: management of hyperglycemia in type 2 diabetes, 2018. a consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 43:487\u2013493. https:\/\/doi.org\/10.2337\/dci19-0066","journal-title":"Diabetes Care"},{"key":"2237_CR5","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","volume":"45","author":"C Vrints","year":"2024","unstructured":"Vrints C, Andreotti F, Koskinas KC, Rossello X, Adamo M, Ainslie J et al (2024) 2024 ESC guidelines for the management of chronic coronary syndromes. Eur Heart J 45:3415\u20133537. https:\/\/doi.org\/10.1093\/eurheartj\/ehae177","journal-title":"Eur Heart J"},{"key":"2237_CR6","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","volume":"373","author":"B Zinman","year":"2015","unstructured":"Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S et al (2015) Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med 373:2117\u20132128. https:\/\/doi.org\/10.1056\/NEJMoa1504720","journal-title":"N Engl J Med"},{"key":"2237_CR7","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1603827","volume":"375","author":"SP Marso","year":"2016","unstructured":"Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JFE, Nauck MA et al (2016) Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med 375:311\u2013322. https:\/\/doi.org\/10.1056\/NEJMoa1603827","journal-title":"N Engl J Med"},{"key":"2237_CR8","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.jcmg.2011.08.007","volume":"4","author":"M Mizoguchi","year":"2011","unstructured":"Mizoguchi M, Tahara N, Tahara A, Nitta Y, Kodama N, Oba T et al (2011) Pioglitazone attenuates atherosclerotic plaque inflammation in patients with impaired glucose tolerance or diabetes a prospective, randomized, comparator-controlled study using serial FDG PET\/CT imaging study of carotid artery and ascending aorta. JACC Cardiovasc Imaging 4:1110\u20131118. https:\/\/doi.org\/10.1016\/j.jcmg.2011.08.007","journal-title":"JACC Cardiovasc Imaging"},{"key":"2237_CR9","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.vph.2020.106779","volume":"133","author":"Y Kang","year":"2020","unstructured":"Kang Y, Zhan F, He M, Liu Z, Song X (2020) Anti-inflammatory effects of sodium-glucose co-transporter 2 inhibitors on atherosclerosis. Vascul Pharmacol 133:133\u2013134. https:\/\/doi.org\/10.1016\/j.vph.2020.106779","journal-title":"Vascul Pharmacol"},{"key":"2237_CR10","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1161\/CIRCULATIONAHA.118.038868","volume":"139","author":"TA Zelniker","year":"2019","unstructured":"Zelniker TA, Wiviott SD, Raz I, Im K, Goodrich EL, Furtado RHM, Im KA et al (2019) Comparison of the effects of glucagon-like peptide receptor agonists and sodium-glucose cotransporter 2 inhibitors for prevention of major adverse cardiovascular and renal outcomes in type 2 diabetes mellitus. Circulation 139:2022\u20132031. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.118.038868","journal-title":"Circulation"},{"key":"2237_CR11","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1016\/j.jacc.2016.02.026","volume":"67","author":"MC Williams","year":"2016","unstructured":"Williams MC, Hunter A, Shah ASV, Assi V, Lewis S, Smith J et al (2016) Use of coronary computed tomographic angiography to guide management of patients with coronary disease. J Am Coll Cardiol 67:1759\u20131768. https:\/\/doi.org\/10.1016\/j.jacc.2016.02.026","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"2237_CR12","first-page":"505","volume":"16","author":"MC Williams","year":"2023","unstructured":"Williams MC (2023) Predictors of plaque progression on coronary computed tomography angiography. Cardiovasc Imaging 16(4):505\u2013507","journal-title":"Cardiovasc Imaging"},{"key":"2237_CR13","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.jcct.2014.07.003","volume":"8","author":"J Leipsic","year":"2014","unstructured":"Leipsic J, Abbara S, Achenbach S, Cury R, Earls JP, Mancini GJ et al (2014) SCCT guidelines for the interpretation and reporting of coronary CT angiography: a report of the society of cardiovascular computed tomography guidelines committee. J Cardiovasc Comput Tomogr 8:342\u2013358. https:\/\/doi.org\/10.1016\/j.jcct.2014.07.003","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"2237_CR14","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.jcct.2017.07.002","volume":"11","author":"H Gu","year":"2017","unstructured":"Gu H, Gao Y, Wang H, Hou Z, Han L, Wang X et al (2017) Sex differences in coronary atherosclerosis progression and major adverse cardiac events in patients with suspected coronary artery disease. J Cardiovasc Comput Tomogr 11:367\u2013372. https:\/\/doi.org\/10.1016\/j.jcct.2017.07.002","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"2237_CR15","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.ijcard.2017.05.062","volume":"243","author":"Y Lei","year":"2017","unstructured":"Lei Y, Yang G, Hu L, Piao L, Inoue A, Jiang H et al (2017) Increased dipeptidyl peptidase-4 accelerates diet-related vascular aging and atherosclerosis in ApoE-deficient mice under chronic stress. Int J Cardiol 243:413\u2013420. https:\/\/doi.org\/10.1016\/j.ijcard.2017.05.062","journal-title":"Int J Cardiol"},{"key":"2237_CR16","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1161\/CIRCULATIONAHA.111.041418","volume":"124","author":"Z Shah","year":"2011","unstructured":"Shah Z, Kampfrath T, Deiuliis JA, Zhong J, Pineda C, Ying Z et al (2011) Long-term dipeptidyl-peptidase 4 inhibition reduces atherosclerosis and inflammation via effects on monocyte recruitment and chemotaxis. Circulation 124:2338\u20132349. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.041418","journal-title":"Circulation"},{"key":"2237_CR17","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12933-017-0623-6","volume":"16","author":"Y Tian","year":"2017","unstructured":"Tian Y, Chen T, Wu Y, Yang L, Wang L, Fan X et al (2017) Pioglitazone stabilizes atherosclerotic plaque by regulating the Th17\/Treg balance in AMPK-dependent mechanisms. Cardiovasc Diabetol 16:140. https:\/\/doi.org\/10.1186\/s12933-017-0623-6","journal-title":"Cardiovasc Diabetol"},{"key":"2237_CR18","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.jacbts.2018.09.004","volume":"3","author":"G Rakipovski","year":"2018","unstructured":"Rakipovski G, Rolin B, N\u00f8hr J, Klewe I, Frederiksen KS, Augustin R et al (2018) The GLP-1 analogs liraglutide and semaglutide reduce atherosclerosis in ApoE-\/- and LDLr-\/- mice by a mechanism that includes inflammatory pathways. JACC Basic Transl Sci 3:844\u2013857. https:\/\/doi.org\/10.1016\/j.jacbts.2018.09.004","journal-title":"JACC Basic Transl Sci"},{"key":"2237_CR19","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41569-023-00849-3","volume":"20","author":"JR Ussher","year":"2023","unstructured":"Ussher JR, Drucker DJ (2023) Glucagon-like peptide 1 receptor agonists: cardiovascular benefits and mechanisms of action. Nat Rev Cardiol 20:463\u2013474. https:\/\/doi.org\/10.1038\/s41569-023-00849-3","journal-title":"Nat Rev Cardiol"},{"key":"2237_CR20","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.cmet.2018.03.001","volume":"27","author":"DJ Drucker","year":"2018","unstructured":"Drucker DJ (2018) Mechanisms of action and therapeutic application of glucagon-like peptide-1. Cell Metab 27:740\u2013756. https:\/\/doi.org\/10.1016\/j.cmet.2018.03.001","journal-title":"Cell Metab"},{"key":"2237_CR21","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3390\/metabo12020183","volume":"12","author":"I Caruso","year":"2022","unstructured":"Caruso I, Cignarelli A, Sorice GP, Natalicchio A, Perrini S, Laviola L et al (2022) Cardiovascular and renal effectiveness of GLP-1 receptor agonists vs. other glucose-lowering drugs in type 2 diabetes: a systematic review and meta-analysis of real-world studies. Metabolites 12:183. https:\/\/doi.org\/10.3390\/metabo12020183","journal-title":"Metabolites"},{"key":"2237_CR22","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1056\/NEJMoa1812389","volume":"380","author":"SD Wiviott","year":"2019","unstructured":"Wiviott SD, Raz I, Bonaca MP, Mosenzon O, Kato ET, Cahn A et al (2019) Dapagliflozin and cardiovascular outcomes in type 2 diabetes. N Engl J Med 380:347\u2013357. https:\/\/doi.org\/10.1056\/NEJMoa1812389","journal-title":"N Engl J Med"},{"key":"2237_CR23","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.amjcard.2019.10.028","volume":"124","author":"S Verma","year":"2019","unstructured":"Verma S (2019) Potential mechanisms of sodium-glucose Co-transporter 2 inhibitor-related cardiovascular benefits. Am J Cardiol 124:36\u201344. https:\/\/doi.org\/10.1016\/j.amjcard.2019.10.028","journal-title":"Am J Cardiol"},{"key":"2237_CR24","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1161\/CIRCULATIONAHA.119.042375","volume":"140","author":"S Verma","year":"2019","unstructured":"Verma S, Mazer CD, Yan AT, Mason T, Garg V, Teoh H et al (2019) Effect of empagliflozin on left ventricular mass in patients With Type 2 diabetes mellitus and coronary artery disease: the EMPA-HEART cardiolink-6 randomized clinical trial. Circulation 140:1693\u20131702. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.042375","journal-title":"Circulation"},{"key":"2237_CR25","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.3390\/nu15102294","volume":"15","author":"D Kounatidis","year":"2023","unstructured":"Kounatidis D, Vallianou N, Evangelopoulos A, Vlahodimitris I, Grivakou E, Kotsi E et al (2023) SGLT-2 inhibitors and the inflammasome: What\u2019s next in the 21st century? Nutrients 15:2294. https:\/\/doi.org\/10.3390\/nu15102294","journal-title":"Nutrients"},{"key":"2237_CR26","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1097\/MOL.0000000000000340","volume":"27","author":"J Zhong","year":"2016","unstructured":"Zhong J, Kankanala S, Rajagopalan S (2016) Dipeptidyl peptidase-4 inhibition: insights from the bench and recent clinical studies. Curr Opin Lipidol 27:484\u2013492. https:\/\/doi.org\/10.1097\/MOL.0000000000000340","journal-title":"Curr Opin Lipidol"},{"key":"2237_CR27","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12933-017-0558-y","volume":"16","author":"L Duan","year":"2017","unstructured":"Duan L, Rao X, Xia C, Rajagopalan S, Zhong J (2017) The regulatory role of DPP-4 in atherosclerotic disease. Cardiovasc Diabetol 16:76. https:\/\/doi.org\/10.1186\/s12933-017-0558-y","journal-title":"Cardiovasc Diabetol"},{"key":"2237_CR28","doi-asserted-by":"publisher","first-page":"e005855","DOI":"10.1161\/CIRCHEARTFAILURE.118.005855","volume":"12","author":"SV Arnold","year":"2019","unstructured":"Arnold SV, Inzucchi SE, Echouffo-Tcheugui JB, Tang F, Lam CSP, Sperling LS et al (2019) Understanding contemporary use of thiazolidinediones. Circ Heart Fail 12:e005855. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.118.005855","journal-title":"Circ Heart Fail"}],"container-title":["La radiologia medica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-026-02237-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11547-026-02237-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-026-02237-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:31:09Z","timestamp":1791826269000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11547-026-02237-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":28,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["2237"],"URL":"https:\/\/doi.org\/10.1007\/s11547-026-02237-6","relation":{},"ISSN":["1826-6983"],"issn-type":[{"value":"1826-6983","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"assertion":[{"value":"13 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest related to this work. Kaiyue Diao is an editor of this journal but was not involved in the review or decision-making process for this manuscript.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Biomedical Research Ethics Committee of West China Hospital (No.2025\u2013791) and complied with the Declaration of Helsinki.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study utilized data from the Establishment of a Cohort for Continuous Coronary CTA Scanning and Predictive Analysis of Plaque Progression (TOCCATA) registry (NCT06660485).","order":3,"name":"Ethics","label":"Clinical trial registry","group":{"name":"EthicsHeading","label":"Declarations"}}]}}